Cara Ferreira

Title: The Innovative Contributions of Cara Ferreira

Introduction

Cara Ferreira is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of diagnostics, particularly in the development of formulations that aid in the diagnosis of Parkinson's disease. With a total of 3 patents to her name, Ferreira's work exemplifies the intersection of innovation and healthcare.

Latest Patents

One of Ferreira's latest patents is a labeled iodinated tropane formulation. This diagnostic formulation comprises a tropane with a radioactive concentration of at least 1.6 mCi/mL, maintained for at least about 51 hours post-creation. The formulation optionally includes a radiolabeled dopamine transporter (DAT) ligand, which is useful in diagnosing Parkinson's disease. An example of such a ligand is [I]-2β-carbomethoxy-3β-(4-fluorophenyl)-N-(3-iodo-E-allyl)nortropane. This innovative approach has the potential to enhance diagnostic accuracy and patient outcomes.

Career Highlights

Throughout her career, Cara Ferreira has worked with several prominent companies, including Alseres Pharmaceuticals, Inc. and Likeminds, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical field.

Collaborations

Ferreira has collaborated with notable professionals in her field, including Chris Sterzinger and David Leyh. These partnerships have fostered an environment of innovation and have led to the development of her impactful patents.

Conclusion

Cara Ferreira's contributions to the field of diagnostics through her innovative patents highlight her role as a leading inventor. Her work not only advances medical technology but also improves the lives of those affected by Parkinson's disease.